Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01076114 · ClinicalTrials.gov registry record
Comparison of Critical Flicker Fusion Versus Automated Visual Fields in the Detection of Early Glaucoma
A clinical trial, sponsored by Northwell Health.
- Completed
- Registry status
- 58
- Enrollment target
NCT01076114: Completed study, sponsored by Northwell Health.
NCT01076114 is a clinical trial that has completed, run by Northwell Health. The registered enrollment target is 58 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01076114 has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- 58 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate if critical flicker fusion is a more reliable method for detection of early glaucoma compared to automated visual fields in comparison to subjects without evidence of glaucoma or optic nerve disease.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2010-02 |
| Est. Completion | 2011-02 |
What the finished NCT01076114 record still lists
NCT01076114 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 58 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01076114 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01076114 about?
NCT01076114 is a clinical study titled "Comparison of Critical Flicker Fusion Versus Automated Visual Fields in the Detection of Early Glaucoma". The purpose of this study is to evaluate if critical flicker fusion is a more reliable method for detection of early glaucoma compared to automated visual fields in comparison to subjects without evidence of glaucoma or optic nerve disease.
What is the current status of trial NCT01076114?
This trial is currently completed. The enrollment target is 58 participants. The study started on 2010-02. Estimated completion is 2011-02.
Who is sponsoring clinical trial NCT01076114?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03587844 · 58 participants · Phase 2
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
- NCT03630991 · 58 participants · Phase 1
Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
- NCT03949855 · 58 participants · Phase 2
Belimumab With Rituximab for Primary Membranous Nephropathy
- NCT04069273 · 58 participants · Phase 2
Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia